AutismKB 2.0

Annotation Detail for TOP2B


View Evidences View Variants View Annotations
Basic Information Top
Gene Symbol:TOP2B ( TOPIIB,top2beta )
Gene Full Name: topoisomerase (DNA) II beta 180kDa
Band: 3p24.2
Quick LinksEntrez ID:7155; OMIM: 126431; Uniprot ID:TOP2B_HUMAN; ENSEMBL ID: ENSG00000077097; HGNC ID: 11990
Relate to Another Database: SFARIGene; denovo-db
Related Pathway Information Top
Related Diseases/Disorders Top
Comparative Toxicogenomics Database Top
Chemical ID Chemical Name Interaction Interaction Action Publication
C031285 3-xylene 3-xylene results in decreased expression of TOP2B mRNAdecreases expression 12815608
C070899 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione results in increased degradation of and results in decreased expression of TOP2B proteindecreases expression|increases degradation 17875725
C070899 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione bortezomib inhibits the reaction [4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione results in increased degradation of and results in decreased expression of TOP2B protein]decreases expression|decreases reaction|increases degradation 17875725
C009505 4,4'-diaminodiphenylmethane 4,4'-diaminodiphenylmethane results in decreased expression of TOP2B mRNAdecreases expression 18648102
C016601 4-hydroxytamoxifen 4-hydroxytamoxifen results in decreased expression of TOP2B mRNAdecreases expression 16514628
D013196 Dihydrotestosterone TOP2B protein promotes the reaction [Dihydrotestosterone results in increased expression of KLK2 mRNA]increases expression|increases reaction 20601956
D013196 Dihydrotestosterone TOP2B protein promotes the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]increases expression|increases reaction 20601956
D013196 Dihydrotestosterone TOP2B protein promotes the reaction [Dihydrotestosterone results in increased expression of SLC45A3 mRNA]increases expression|increases reaction 20601956
D013196 Dihydrotestosterone TOP2B protein promotes the reaction [Dihydrotestosterone results in increased expression of TMPRSS2 mRNA]increases expression|increases reaction 20601956
D006710 Homocysteine Homocysteine results in decreased expression of TOP2B mRNAdecreases expression 17326132
D000677 Amsacrine TOP2B protein mutant form results in decreased susceptibility to Amsacrinedecreases response to substance 15322234
16549872
16239602
D000677 Amsacrine Amsacrine results in decreased activity of TOP2B proteindecreases activity 16549872
D000728 Androgens Androgens promotes the reaction [TOP2B protein results in increased mutagenesis of ERG gene]increases mutagenesis|increases reaction 20601956
D000728 Androgens Androgens promotes the reaction [TOP2B protein results in increased mutagenesis of TMPRSS2 gene]increases mutagenesis|increases reaction 20601956
C400082 bortezomib bortezomib inhibits the reaction [4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione results in increased degradation of and results in decreased expression of TOP2B protein]decreases expression|decreases reaction|increases degradation 17875725
C400082 bortezomib bortezomib inhibits the reaction [Razoxane results in increased degradation of and results in decreased expression of TOP2B protein]decreases expression|decreases reaction|increases degradation 17875725
D003687 Dehydroepiandrosterone Dehydroepiandrosterone results in decreased expression of TOP2B mRNAdecreases expression 16940010
D004317 Doxorubicin TOP2B affects the susceptibility to Doxorubicinaffects response to substance 16957942
D004317 Doxorubicin TOP2B protein mutant form results in decreased susceptibility to Doxorubicindecreases response to substance 16239602
D004317 Doxorubicin TOP2B protein results in decreased susceptibility to Doxorubicindecreases response to substance 17523305
D004317 Doxorubicin TOP2B protein affects the reaction [Doxorubicin results in increased expression of H2AFX protein]affects reaction|increases expression 17875725
D004317 Doxorubicin TOP2B protein affects the susceptibility to Doxorubicinaffects response to substance 17875725
C034192 ellipticine TOP2B protein mutant form results in decreased susceptibility to ellipticinedecreases response to substance 16239602
C034192 ellipticine TOP2B protein mutant form results in increased susceptibility to ellipticineincreases response to substance 15322234
C045651 epigallocatechin gallate epigallocatechin gallate results in increased expression of TOP2B mRNAincreases expression 18851785
D004958 Estradiol Estradiol results in increased expression of TOP2B mRNAincreases expression 16514628
D005047 Etoposide TOP2B protein mutant form results in decreased susceptibility to Etoposidedecreases response to substance 16239602
D005047 Etoposide TOP2B protein mutant form results in increased susceptibility to Etoposideincreases response to substance 15322234
D005047 Etoposide Etoposide results in decreased expression of TOP2B proteindecreases expression 10856430
D005047 Etoposide TOP2B protein affects the reaction [Etoposide results in increased expression of H2AFX protein]affects reaction|increases expression 17875725
D005047 Etoposide TOP2B protein affects the susceptibility to Etoposideaffects response to substance 17875725
C070081 fulvestrant fulvestrant results in decreased expression of TOP2B mRNAdecreases expression 16514628
D008610 Menthol Menthol results in decreased activity of TOP2B proteindecreases activity 16158947
D020849 Raloxifene Raloxifene results in decreased expression of TOP2B mRNAdecreases expression 16514628
D011929 Razoxane Razoxane binds to TOP2B proteinaffects binding 17875725
D011929 Razoxane bortezomib inhibits the reaction [Razoxane results in increased degradation of and results in decreased expression of TOP2B protein]decreases expression|decreases reaction|increases degradation 17875725
D011929 Razoxane Razoxane results in increased degradation of and results in decreased expression of TOP2B proteindecreases expression|increases degradation 17875725
D014415 Tunicamycin Tunicamycin results in increased expression of TOP2B mRNAincreases expression 17127020
Disease ID Disease Name Direct Evidence Inference Chemical Name Inference Score Publication
MESH:D055371 Acute Lung Injury 3-xylene 5.2415204773
MESH:D000230 Adenocarcinoma Doxorubicin 4.4217418594
MESH:D000230 Adenocarcinoma Estradiol 4.4211473722
MESH:D000236 Adenoma 4,4'-diaminodiphenylmethane 2.703712494
MESH:D000309 Adrenal Insufficiency Dehydroepiandrosterone 5.6817302879
MESH:D000419 Albuminuria Doxorubicin 11.1721441931
MESH:D000419 Albuminuria Raloxifene 11.1717308373 17451421
MESH:D000544 Alzheimer Disease Androgens 4.7417182789 17917157
MESH:D000544 Alzheimer Disease Raloxifene 4.7415800139
MESH:D001249 Asthma epigallocatechin gallate 3.3616516891
MESH:D001284 Atrophy fulvestrant 4.7611514358
MESH:D001321 Autistic Disorder Homocysteine 3.0516297937 20468076
MESH:D001327 Autoimmune Diseases epigallocatechin gallate 4.9819761891
MESH:D001660 Biliary Tract Diseases 4,4'-diaminodiphenylmethane 4.941440618 11289319
MESH:D019046 Bone Marrow Neoplasms Doxorubicin 11.8914601052
MESH:D019046 Bone Marrow Neoplasms Etoposide 11.8914601052
MESH:D001930 Brain Injuries Raloxifene 4.3916580743
MESH:D001932 Brain Neoplasms Doxorubicin 3.7317150277
MESH:D001943 Breast Neoplasms Androgens 2.9417018787
MESH:D001943 Breast Neoplasms Doxorubicin 2.9418382427 15692762 15939500 15994142 18695136 11325840 16264153 16595493 16935488 15668708 15136595 16115903 15993339 17426702 19526202 16096432 15634643 16826403 17369602 18628466 18234424 15567936 16322301 17983394
MESH:D001943 Breast Neoplasms Estradiol 2.9412948864 17289903 19861407 18497071 14630087 16675129 17261762 17018787
MESH:D001943 Breast Neoplasms Etoposide 2.9416322251
MESH:D001943 Breast Neoplasms fulvestrant 2.9418984771
MESH:D001943 Breast Neoplasms Raloxifene 2.9415775269 16912660 17893378 15572757 17242785 17440819 15758505 17952589 16837676 17595753 17261762 17049068
MESH:D002181 Candidiasis, Vulvovaginal Estradiol 4.3816111702
MESH:D002276 Carcinoid Tumor Doxorubicin 4.7316051944
MESH:D006528 Carcinoma, Hepatocellular 4,4'-diaminodiphenylmethane 4.547296757 3581430
MESH:D006528 Carcinoma, Hepatocellular Doxorubicin 4.5416234567 16023760 18059187 17876044
MESH:D006528 Carcinoma, Hepatocellular Estradiol 4.5416924424
MESH:D002289 Carcinoma, Non-Small-Cell Lung bortezomib 3.9216052434
MESH:D002292 Carcinoma, Renal Cell 4,4'-diaminodiphenylmethane 6.417296757
MESH:D002292 Carcinoma, Renal Cell Doxorubicin 6.411485588 16201981
MESH:D002294 Carcinoma, Squamous Cell Doxorubicin 2.616189445
MESH:D002295 Carcinoma, Transitional Cell Raloxifene 3.9917572228
MESH:D009202 Cardiomyopathies Doxorubicin 8.3716455267 17974986 17007740 16731534 16612575 15505089 17131338 18627295 16242529 16278810 16364871 15792986 17519947 17928571 15476868 17329180 17924179 16109756 16952015 15811867 17351982 17308081 16651473 17382496 16269455
MESH:D009202 Cardiomyopathies Razoxane 8.3717519947
MESH:D002311 Cardiomyopathy, Dilated Doxorubicin 2.9216243910 17334414
MESH:D002318 Cardiovascular Diseases Raloxifene 3.3815775269
MESH:D002471 Cell Transformation, Neoplastic 4,4'-diaminodiphenylmethane 6.467505956
MESH:D002471 Cell Transformation, Neoplastic Estradiol 6.4618566989
MESH:D002779 Cholestasis 4,4'-diaminodiphenylmethane 3.089022650 19486331
MESH:D003072 Cognition Disorders Raloxifene 4.5315800139
MESH:D015179 Colorectal Neoplasms Doxorubicin 2.1418802399 18259882
MESH:D003324 Coronary Artery Disease Homocysteine 3.7216379339
MESH:D016638 Critical Illness Androgens 5.9716670151
MESH:D003865 Depressive Disorder, Major Raloxifene 4.0817474826
MESH:D003872 Dermatitis 3-xylene 5.8012717741 15902427
MESH:D017449 Dermatitis, Allergic Contact 4,4'-diaminodiphenylmethane 2.722524372 18759878 14531868 11298694 11906362 8156756 12868966 8970840
MESH:D003877 Dermatitis, Contact 4,4'-diaminodiphenylmethane 3.412952479 3621924
MESH:D003922 Diabetes Mellitus, Type 1 Dehydroepiandrosterone 3.6716616286
MESH:D003924 Diabetes Mellitus, Type 2 epigallocatechin gallate 3.2616988119
MESH:D003928 Diabetic Nephropathies Estradiol 8.7519279558
MESH:D003928 Diabetic Nephropathies Raloxifene 8.7515920148 17308373 17451421
MESH:D056486 Drug-Induced Liver Injury 4,4'-diaminodiphenylmethane 3.949022650 9653073 18289764 7440962 11289319 8291058 18692083 16192314 6482804 18648102 1440618 6679447 9328219
MESH:D056486 Drug-Induced Liver Injury Doxorubicin 3.9417416283
MESH:D004362 Drug Toxicity Doxorubicin 3.6018602426
MESH:D004487 Edema Raloxifene 3.2615860553
MESH:D004681 Encephalomyelitis, Autoimmune, Experimental Raloxifene 3.9115845917
MESH:D016889 Endometrial Neoplasms 4-hydroxytamoxifen 12.2819148513
MESH:D016889 Endometrial Neoplasms Doxorubicin 12.2817359293
MESH:D016889 Endometrial Neoplasms Estradiol 12.2819148513 18566989 11473722
MESH:D004719 Endomyocardial Fibrosis Doxorubicin 5.0818037988
MESH:D004938 Esophageal Neoplasms 4,4'-diaminodiphenylmethane 2.093581430
MESH:D017889 Exfoliation Syndrome Homocysteine 5.6216504073
MESH:D005234 Fatty Liver Raloxifene 3.5417473493
MESH:D005350 Fibroma 4,4'-diaminodiphenylmethane 4.946705139
MESH:D018222 Fibromatosis, Aggressive Doxorubicin 4.5019069698
MESH:D005901 Glaucoma Homocysteine 5.2016504073
MESH:D005909 Glioblastoma Doxorubicin 3.2917150277
MESH:D006042 Goiter 4,4'-diaminodiphenylmethane 3.957505956
MESH:D006258 Head and Neck Neoplasms Doxorubicin 3.4715692506
MESH:D006330 Heart Defects, Congenital Homocysteine 3.9619638421
MESH:D006331 Heart Diseases Doxorubicin 12.6516707910 16879835 17888722 16495754 16144979 16244372 16330681 18006777 14766674 17875725 16244371 12587719 18674790
MESH:D006331 Heart Diseases Raloxifene 12.6511110106
MESH:D006331 Heart Diseases Razoxane 12.6517875725
MESH:D006333 Heart Failure Doxorubicin 3.2917481944
MESH:D006390 Hemangioendothelioma Razoxane 6.3215380572
MESH:D006394 Hemangiosarcoma Doxorubicin 3.8215692506
MESH:D006505 Hepatitis 4,4'-diaminodiphenylmethane 3.436705139
MESH:D006558 Herpes Genitalis Estradiol 4.9515709030
MESH:D006561 Herpes Simplex Amsacrine 10.3510809021
MESH:D006561 Herpes Simplex Etoposide 10.3510809021
MESH:D006628 Hirsutism Androgens 6.0016914592 17019078
MESH:D006689 Hodgkin Disease Doxorubicin 7.4915147373 17606976 18501091
MESH:D006689 Hodgkin Disease Etoposide 7.4918180244 17606976 16200630 15147373 16135485
MESH:D019584 Hot Flashes Estradiol 3.6717088409
MESH:D017588 Hyperandrogenism Androgens 5.6517019078
MESH:D006934 Hypercalcemia bortezomib 5.3718089816
MESH:D020138 Hyperhomocysteinemia Homocysteine 4.6317292331 18234410 17369066
MESH:D006965 Hyperplasia 4,4'-diaminodiphenylmethane 3.8515034207
MESH:D006973 Hypertension Raloxifene 2.8315787275 17577099
MESH:D007248 Infertility, Male fulvestrant 3.6911514358
MESH:D007333 Insulin Resistance Estradiol 2.9116393666 16627594
MESH:D007565 Jaundice 4,4'-diaminodiphenylmethane 4.949022650 8074119
MESH:D007674 Kidney Diseases Doxorubicin 6.0315369732 15699352 16775033
MESH:D007674 Kidney Diseases Estradiol 6.0315618244
MESH:D007676 Kidney Failure, Chronic Doxorubicin 4.0716707910
MESH:D007680 Kidney Neoplasms 4,4'-diaminodiphenylmethane 7.116582329
MESH:D007680 Kidney Neoplasms Estradiol 7.1115610895
MESH:D007889 Leiomyoma Raloxifene 4.4116973256
MESH:D004915 Leukemia, Erythroblastic, Acute Doxorubicin 5.0816085563
MESH:D015459 Leukemia-Lymphoma, Adult T-Cell bortezomib 5.0918089816
MESH:D007951 Leukemia, Myeloid therapeutic 16932348
MESH:D015470 Leukemia, Myeloid, Acute Amsacrine 5.0318043129 15148258
MESH:D015470 Leukemia, Myeloid, Acute bortezomib 5.0320471514
MESH:D008105 Liver Cirrhosis, Biliary 4,4'-diaminodiphenylmethane 3.149327722 15034207
MESH:D008106 Liver Cirrhosis, Experimental Doxorubicin 3.6516439617 16595196
MESH:D008106 Liver Cirrhosis, Experimental epigallocatechin gallate 3.6517481882
MESH:D008106 Liver Cirrhosis, Experimental Estradiol 3.6514659978 14716833
MESH:D008113 Liver Neoplasms Dehydroepiandrosterone 3.4518709148
MESH:D008114 Liver Neoplasms, Experimental 4,4'-diaminodiphenylmethane 9.753712494 1399818 6587162 598648
MESH:D008114 Liver Neoplasms, Experimental Dehydroepiandrosterone 9.758603461
MESH:D008114 Liver Neoplasms, Experimental Doxorubicin 9.7516842330 17085340
MESH:D008175 Lung Neoplasms Doxorubicin 2.1417418594 6189445
MESH:D008223 Lymphoma bortezomib 12.4816098063
MESH:D008223 Lymphoma Doxorubicin 12.4816098063
MESH:D008223 Lymphoma Etoposide 12.4812854902 12556972
MESH:D016393 Lymphoma, B-Cell bortezomib 5.2316675587
MESH:D008228 Lymphoma, Non-Hodgkin Doxorubicin 3.7217654614
MESH:D016399 Lymphoma, T-Cell Doxorubicin 4.4815621674
MESH:D008325 Mammary Neoplasms, Experimental Dehydroepiandrosterone 9.8316457693
MESH:D008325 Mammary Neoplasms, Experimental Doxorubicin 9.8315458769
MESH:D008325 Mammary Neoplasms, Experimental Estradiol 9.8317203775 11807958 16891317 11408345
MESH:D020149 Manganese Poisoning Estradiol 4.4019453300
MESH:D008527 Medulloblastoma bortezomib 4.1919213072
MESH:D008545 Melanoma Doxorubicin 3.7716827129
MESH:D008545 Melanoma epigallocatechin gallate 3.7717992120 11746506
MESH:D008591 Meningomyelocele Homocysteine 5.4516602021
MESH:D008654 Mesothelioma Doxorubicin 3.0217638057
MESH:D028361 Mitochondrial Diseases Doxorubicin 4.4215792986
MESH:D018200 Mixed Tumor, Mullerian Raloxifene 5.4715863610
MESH:D052016 Mucositis Doxorubicin 4.7017415656
MESH:D009101 Multiple Myeloma bortezomib 7.7119112201 19112817 19372569
MESH:D009101 Multiple Myeloma Raloxifene 7.7116497877
MESH:D009134 Muscular Atrophy, Spinal epigallocatechin gallate 5.4117962980
MESH:D009203 Myocardial Infarction Doxorubicin 6.1719429709 15857846
MESH:D009203 Myocardial Infarction Homocysteine 6.1717412321
MESH:D015428 Myocardial Reperfusion Injury Estradiol 3.2116810080
MESH:D009232 Myxoma Raloxifene 5.4716343187
MESH:D009362 Neoplasm Metastasis 4,4'-diaminodiphenylmethane 5.733581430
MESH:D009362 Neoplasm Metastasis Doxorubicin 5.7318259882
MESH:D009389 Neovascularization, Pathologic Estradiol 3.6517289903
MESH:D009401 Nephrosis Doxorubicin 4.6816899518 16636307
MESH:D009404 Nephrotic Syndrome Doxorubicin 3.9216889571 15640375
MESH:D009421 Nervous System Malformations Estradiol 3.5611399458 16427766
MESH:D009436 Neural Tube Defects 4,4'-diaminodiphenylmethane 2.866679447
MESH:D009447 Neuroblastoma Doxorubicin 3.2215555623
MESH:D020258 Neurotoxicity Syndromes 3-xylene 4.927820390 8907413
MESH:D009784 Occupational Diseases 4,4'-diaminodiphenylmethane 3.344026338 6482804
MESH:D009902 Optic Neuritis 4,4'-diaminodiphenylmethane 4.943988306
MESH:D010024 Osteoporosis Raloxifene 3.3417882678 19059307 15775268
MESH:D015663 Osteoporosis, Postmenopausal Dehydroepiandrosterone 10.2116397352
MESH:D015663 Osteoporosis, Postmenopausal Raloxifene 10.2115758505 15579764 17823083 17893378
MESH:D012516 Osteosarcoma Doxorubicin 4.0415930896
MESH:D010051 Ovarian Neoplasms Estradiol 2.1919401270
MESH:D010190 Pancreatic Neoplasms Etoposide 3.2419003803
MESH:D010212 Papilloma 4,4'-diaminodiphenylmethane 3.407296757
MESH:D010300 Parkinson Disease Homocysteine 3.5416275827
MESH:D010787 Photosensitivity Disorders 4,4'-diaminodiphenylmethane 4.396228378
MESH:D003557 Phyllodes Tumor Doxorubicin 5.0817983394
MESH:D010997 Pleural Neoplasms Doxorubicin 5.0817638057
MESH:D019048 Prostatic Intraepithelial Neoplasia marker/mechanism 20601956
MESH:D019048 Prostatic Intraepithelial Neoplasia Estradiol 3.8020887781
MESH:D011471 Prostatic Neoplasms Androgens 1.9116998812 17909013 15389811
MESH:D011471 Prostatic Neoplasms Doxorubicin 1.9116868541 15749863 18437689 16729912 15897917 16888761
MESH:D011471 Prostatic Neoplasms Estradiol 1.9116740699
MESH:D011471 Prostatic Neoplasms Etoposide 1.9117172428
MESH:D011471 Prostatic Neoplasms Raloxifene 1.9116536755 16220300 15731164
MESH:D011693 Purpura Raloxifene 5.4715770314
MESH:D051437 Renal Insufficiency Doxorubicin 4.1317922066
MESH:D012162 Retinal Degeneration 4,4'-diaminodiphenylmethane 3.313692021
MESH:D012509 Sarcoma Doxorubicin 3.9115675481 17203757 17710206 16767912 18313854 15625365
MESH:D012512 Sarcoma, Ewing's Doxorubicin 10.2616326096 14601052
MESH:D012512 Sarcoma, Ewing's Etoposide 10.2614601052
MESH:D012514 Sarcoma, Kaposi Doxorubicin 4.7017846226
MESH:D012559 Schizophrenia Homocysteine 3.0916641680
MESH:D012640 Seizures 3-xylene 4.358907413 6431079
MESH:D012878 Skin Neoplasms Doxorubicin 2.9115692506
MESH:D012983 Soft Tissue Neoplasms Doxorubicin 4.4817203757 16767912 15625365
MESH:D020521 Stroke Raloxifene 3.7516837676
MESH:D013964 Thyroid Neoplasms 4,4'-diaminodiphenylmethane 7.036582329 1399818 3712494 6587162 7505956
MESH:D013964 Thyroid Neoplasms Doxorubicin 7.0316010429 17909728
MESH:D013978 Tibial Fractures Estradiol 13.4419048282
MESH:D013978 Tibial Fractures Raloxifene 13.4419048282
MESH:D001749 Urinary Bladder Neoplasms 4,4'-diaminodiphenylmethane 8.218074119
MESH:D001749 Urinary Bladder Neoplasms Doxorubicin 8.2117653716
MESH:D001749 Urinary Bladder Neoplasms Raloxifene 8.2117572228
MESH:D054556 Venous Thromboembolism Raloxifene 5.1316837676
MESH:D018487 Ventricular Dysfunction, Left Doxorubicin 4.1317638931 17678736 16364871 17334414
MESH:D014846 Vulvar Neoplasms Raloxifene 5.4716343187
No data
Pharmacogenomics Knowledge Base Top
  • PharmGKB Accession:PA36672
    • No data
    Releated disease ID Related disease Name
    PA445062Neoplasms
    PA444760Leukemia, Myeloid, Acute
    PA446155Precursor Cell Lymphoblastic Leukemia-Lymphoma
    Releated drug ID Related drug Name
    PA449412doxorubicin
    PA449552etoposide
    Drug Bank Top
    Drugbank ID Action Drug Name Description
    DB00694 antagonist Daunorubicin Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic
    DB02444 - Icrf-187 Antineoplastic Agents;Cardiovascular Agents;Chelating Agents
    DB04395 - Phosphoaminophosphonic Acid-Adenylate Ester
    DB08651 - 3'-THIO-THYMIDINE-5'-PHOSPHATE
    No data
    No data
    No data

    Simple Query:


      (e.g. CHD8)

    Syndromic Genes

    Non-syndromic Genes

    AutismKB Statistics

    • Studies: 1,036
    • Genes: 1,379
    • CNVs/SVs: 5,420
    • SNVs/Indels: 11,669
    • de novo Mutations: 5,669
    • Mosaics: 789
    • Linkage Regions: 172
    • Paper Collected: 6/30/2018
    • Last Update: 8/26/2018


    Copyright © 2017, Center for Bioinformatics , Peking University | All Rights Reserved